Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

27 Aug 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/asymchem-expands-flow-chemistry-capabilities-in-the-uk/

12 Nov 2024
// BUSINESSWIRE

06 Nov 2024
// BUSINESSWIRE

30 Oct 2024
// BUSINESSWIRE

02 Aug 2024
// BUSINESSWIRE

26 Jun 2024
// BUSINESSWIRE
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the terms of the agreement, AUM and Asymchem agree to collaborate on the process development, and the clinical and commercial production, of AUM 601, which is a highly selective oral small-molecule inhibitor of the tropomyosin receptor kinase for treating rare cancers.
Lead Product(s): AUM601,Inapplicable
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Recipient: AUM Biosciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 11, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : AUM601,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Phase I
Recipient : AUM Biosciences
Deal Size : Undisclosed
Deal Type : Collaboration
AUM Biosciences Identifies Asymchem as the CDMO Partner of Choice for their Novel TRK inhibitor
Details : Under the terms of the agreement, AUM and Asymchem agree to collaborate on the process development, and the clinical and commercial production, of AUM 601, which is a highly selective oral small-molecule inhibitor of the tropomyosin receptor kinase for t...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 11, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The partnership between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives.
Lead Product(s): Undisclosed,Inapplicable
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: LaNova Medicines
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership September 16, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : LaNova Medicines
Deal Size : Undisclosed
Deal Type : Partnership
Asymchem and LaNova Medicines Enter into Partnership Agreement, Expanding Biological Capabilities
Details : The partnership between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 16, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the terms of the agreement, Asymchem will implement fermentation, verify protein expression and ultimately fine-tune the technology suitable for production of MS1819.
Lead Product(s): Yeast Recombinant Lipase,Undisclosed
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Enzyme
Sponsor: First Wave BioPharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 10, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Yeast Recombinant Lipase,Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : First Wave BioPharma
Deal Size : Undisclosed
Deal Type : Partnership
Details : Under the terms of the agreement, Asymchem will implement fermentation, verify protein expression and ultimately fine-tune the technology suitable for production of MS1819.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Undisclosed
November 10, 2020

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Services
API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Photochemistry
Pharma Service : API & Drug Product Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients
Inspections and registrations
District Decision : No Action Indicated
Inspection End Date : 2014-05-22
City : Tianjin
State :
Country/Area : China
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2014-05-22

District Decision : Voluntary Action Indicated
Inspection End Date : 2014-05-16
City : Fuxin
State :
Country/Area : China
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-05-16

District Decision : Voluntary Action Indicated
Inspection End Date : 2011-05-18
City : Tianjin
State :
Country/Area : China
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2011-05-18

District Decision : Voluntary Action Indicated
Inspection End Date : 2011-05-12
City : Fuxin
State :
Country/Area : China
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2011-05-12

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Manufacturer : API MANUFACTURE
FDF Manufacturer :
Facility Name : Asychem Laboratories (Tianjin)...
Business Address : No.6 Dongting 3rd Avenue,TED...
FEI Number : 3005354924
Country : China
Paid in : 2019

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Country : China
City/Region : Tianjin
Audit Date : 2023-01-09
Audit Type : On-Site
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Asymchem Laboratories is a supplier offers 21 products (APIs, Excipients or Intermediates).
Find a price of CAS 90776-59-3 bulk with DMF offered by Asymchem Laboratories
Find a price of Dexmedetomidine Hydrochloride bulk with DMF offered by Asymchem Laboratories
Find a price of Liraglutide bulk with DMF offered by Asymchem Laboratories
Find a price of Sapropterin Hydrochloride bulk with DMF offered by Asymchem Laboratories
Find a price of Semaglutide bulk with DMF offered by Asymchem Laboratories
Find a price of MC-VC-PAB-MMAE bulk with DMF offered by Asymchem Laboratories
Find a price of Anastrozole bulk offered by Asymchem Laboratories
Find a price of Atazanavir Sulfate bulk offered by Asymchem Laboratories
Find a price of Atorvastatin bulk offered by Asymchem Laboratories
Find a price of Erlotinib Hydrochloride bulk offered by Asymchem Laboratories
Find a price of Ertapenem bulk offered by Asymchem Laboratories
Find a price of Repaglinide bulk offered by Asymchem Laboratories
Find a price of Salmeterol Xinafoate bulk offered by Asymchem Laboratories
Find a price of Sumatriptan bulk offered by Asymchem Laboratories
Find a price of Tamoxifen Citrate bulk offered by Asymchem Laboratories
Find a price of Toremifene Citrate bulk offered by Asymchem Laboratories
Find a price of Adagrasib bulk offered by Asymchem Laboratories
Find a price of Durlobactam bulk offered by Asymchem Laboratories
Find a price of Fruquintinib bulk offered by Asymchem Laboratories
Find a price of Relacorilant bulk offered by Asymchem Laboratories
Find a price of Repotrectinib bulk offered by Asymchem Laboratories